166 related articles for article (PubMed ID: 1281226)
1. Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model.
Wiranowska M; Gonzalvo AA; Saporta S; Gonzalez OR; Prockop LD
J Neurooncol; 1992 Nov; 14(3):225-36. PubMed ID: 1281226
[TBL] [Abstract][Full Text] [Related]
2. Interferon entry through the blood-brain barrier in glioma and its effect on lipoxygenase activity.
Wiranowska M; Prockop LD; Naidu AK; Saporta S; Kori S; Kulkarni AP
Anticancer Res; 1994; 14(3A):1121-6. PubMed ID: 7521151
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.
Kido G; Wright JL; Merchant RE
J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671
[TBL] [Abstract][Full Text] [Related]
4. Cerebral interferon entry in mice after osmotic alteration of blood-brain barrier.
Wiranowska M; Wilson TC; Thompson K; Prockop LD
J Interferon Res; 1989 Jun; 9(3):353-62. PubMed ID: 2746023
[TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma.
Watts RG; Merchant RE
Neurosurgery; 1992 Jul; 31(1):89-98; discussion 98-9. PubMed ID: 1641114
[TBL] [Abstract][Full Text] [Related]
6. Effects of an intratumoral injection of human recombinant tumor necrosis factor-alpha on cerebrovascular permeability and leukocytic infiltration in a rat glioma model.
Wright JL; Merchant RE
Acta Neuropathol; 1997 Jan; 93(1):78-86. PubMed ID: 9006660
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity.
Brighi C; Reid L; Genovesi LA; Kojic M; Millar A; Bruce Z; White AL; Day BW; Rose S; Whittaker AK; Puttick S
Theranostics; 2020; 10(14):6361-6371. PubMed ID: 32483457
[TBL] [Abstract][Full Text] [Related]
8. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
11. Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier.
Grabb PA; Gilbert MR
J Neurosurg; 1995 Jun; 82(6):1053-8. PubMed ID: 7760177
[TBL] [Abstract][Full Text] [Related]
12. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
13. β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function.
Ziegler N; Awwad K; Fisslthaler B; Reis M; Devraj K; Corada M; Minardi SP; Dejana E; Plate KH; Fleming I; Liebner S
J Neurosci; 2016 Aug; 36(34):8921-35. PubMed ID: 27559173
[TBL] [Abstract][Full Text] [Related]
14. Reduced glioma infiltration in Src-deficient mice.
Lund CV; Nguyen MT; Owens GC; Pakchoian AJ; Shaterian A; Kruse CA; Eliceiri BP
J Neurooncol; 2006 May; 78(1):19-29. PubMed ID: 16552622
[TBL] [Abstract][Full Text] [Related]
15. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
[TBL] [Abstract][Full Text] [Related]
16. [Effect of interferon on mouse glioma].
Nakagawa Y; Suzuki K; Ibayashi N; Ueda S; Hirakawa K; Oku T; Imanishi J; Kishida T
No To Shinkei; 1983 Nov; 35(11):1125-30. PubMed ID: 6197981
[TBL] [Abstract][Full Text] [Related]
17. [The effect of local injection of interferon against human malignant glioma transplanted into nude mice and the mechanism of its effect].
Hori T; Inoue Y; Hokama Y; Yamamoto F; Iwanaga M; Watanabe T
No To Shinkei; 1989 Sep; 41(9):911-7. PubMed ID: 2590560
[TBL] [Abstract][Full Text] [Related]
18. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
[TBL] [Abstract][Full Text] [Related]
19. Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier.
Walter FR; Veszelka S; Pásztói M; Péterfi ZA; Tóth A; Rákhely G; Cervenak L; Ábrahám CS; Deli MA
J Neurochem; 2015 Sep; 134(6):1040-54. PubMed ID: 26112237
[TBL] [Abstract][Full Text] [Related]
20. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
